Barington Capital Accumulates Stake in Chemed and Proposes New Director
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 03 2026
0mins
Source: seekingalpha
- Investor Stake Increase: Barington Capital has accumulated a stake in Chemed (CHE) and proposed former Cerberus Capital Management CEO Chan Galbato as a new board member, indicating confidence in the company's future prospects.
- Management Discussions: Barington has engaged in talks with Chemed's management regarding the potential addition of a new director, highlighting its focus on corporate governance and possibly prompting strategic adjustments within the company.
- Stock Price Reaction: Following the news, Chemed's stock rose by 2%, reflecting a positive market perception of Barington's involvement, despite a 27% decline in stock price over the past year.
- Dividend Declaration: Chemed declared a dividend of $0.60 per share, demonstrating the company's ability to maintain cash flow and shareholder returns in the current market environment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CHE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CHE
Wall Street analysts forecast CHE stock price to rise
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 433.870
Low
475.00
Averages
547.33
High
595.00
Current: 433.870
Low
475.00
Averages
547.33
High
595.00
About CHE
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Chemed Acquires Texas Roto-Rooter Franchise for $12 Million
- Acquisition Deal: Chemed Corporation has acquired a formerly independent Roto-Rooter franchise for approximately $12 million, covering 21 counties in South Texas, including cities like Corpus Christi, McAllen, Laredo, and Brownsville, thereby expanding its market presence.
- Market Leadership: This acquisition is expected to enhance Chemed's service capabilities in Texas, as Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services, which may improve the company's overall business performance and customer base.
- Strategic Implications: By integrating this franchise, Chemed aims to optimize resource allocation and enhance service efficiency, thereby maintaining a competitive edge in a crowded market and meeting the growing customer demand.
- Future Outlook: Chemed's announcement includes caution regarding forward-looking statements, indicating that future performance may be influenced by various factors, urging investors to be aware of potential risks associated with these projections.
See More
Barington Capital Accumulates Stake in Chemed and Proposes New Director
- Investor Stake Increase: Barington Capital has accumulated a stake in Chemed (CHE) and proposed former Cerberus Capital Management CEO Chan Galbato as a new board member, indicating confidence in the company's future prospects.
- Management Discussions: Barington has engaged in talks with Chemed's management regarding the potential addition of a new director, highlighting its focus on corporate governance and possibly prompting strategic adjustments within the company.
- Stock Price Reaction: Following the news, Chemed's stock rose by 2%, reflecting a positive market perception of Barington's involvement, despite a 27% decline in stock price over the past year.
- Dividend Declaration: Chemed declared a dividend of $0.60 per share, demonstrating the company's ability to maintain cash flow and shareholder returns in the current market environment.
See More
Chemed Declares $0.60 Quarterly Dividend, Consistent with Previous Payments
- Dividend Declaration: Chemed has declared a quarterly dividend of $0.60 per share, consistent with previous payments, indicating the company's stable cash flow and profitability, which enhances investor confidence.
- Yield Metrics: The forward yield of 0.54% reflects the company's attractiveness in the current market environment, potentially drawing in more investors seeking stable income.
- Payment Schedule: The dividend is payable on June 16, with a record date of May 28 and an ex-dividend date also on May 28, ensuring shareholders receive their returns promptly, thereby reinforcing shareholder loyalty.
- Consistent Payout Record: Chemed has now announced a $0.60 dividend for four consecutive quarters, demonstrating the company's ongoing commitment to shareholder returns, which may enhance its market position within the healthcare sector.
See More
Chemed Corporation Elects Directors and Declares Dividend at 2026 Annual Meeting
- Board Election: At the 2026 annual meeting, Chemed Corporation's shareholders elected a slate of nine directors, ensuring stability in the governance structure and supporting future strategic decision-making.
- Auditor Reappointment: Shareholders unanimously ratified the continuation of PricewaterhouseCoopers as the independent accountants for 2026, reflecting a commitment to financial transparency and compliance, which enhances investor confidence.
- Shareholder Proposal Rejection: The non-binding proposal regarding executive compensation was not approved, indicating shareholder scrutiny over the company's executive pay policies, which may prompt a review and adjustment of compensation structures in the future.
- Quarterly Cash Dividend: The Board declared a cash dividend of 60 cents per share, payable on June 16, 2026, marking the 220th consecutive quarterly dividend, which underscores Chemed's consistent profitability and commitment to shareholder returns over its 55-year history.
See More
U.S. Temporarily Blocks New Home Health Providers from Medicare Enrollment
- New Medicare Regulations: The U.S. government plans to temporarily block new home health and hospice providers from enrolling in Medicare on Wednesday, reflecting a stringent regulatory approach to combat fraud linked to government-backed healthcare programs.
- Nationwide Moratorium: This nationwide pause aims to address healthcare scams, particularly those affecting Medicare, and is expected to enhance transparency and compliance within the healthcare service sector.
- Anti-Fraud Task Force Actions: Vice President JD Vance's anti-fraud task force will announce several policy changes, emphasizing the crackdown on large-scale fraud, which aims to protect the interests of the American public and demonstrates a zero-tolerance stance towards healthcare fraud.
- Industry-Wide Impact: This move could significantly affect major home health and hospice providers, including BrightSpring Health Services and UnitedHealth, prompting companies within the industry to strengthen compliance measures in response to the new regulatory environment.
See More
Chemtrade Logistics Income Fund Reports Q1 Earnings Decline
- Net Earnings Decline: Chemtrade Logistics Income Fund reported Q1 net earnings of C$25.4 million, a significant decrease of C$23.7 million year-over-year, primarily due to rising finance costs and unfavorable unrealized foreign exchange losses, indicating financial pressure on the company.
- Revenue Performance: The total revenue for Q1 reached C$503 million, showing growth compared to the previous year; however, this increase was insufficient to offset the rising costs, reflecting intensified market competition.
- Adjusted EBITDA Decrease: Adjusted EBITDA stood at C$113.5 million, down C$6.6 million or 5.5% year-over-year, highlighting challenges in profitability that may impact future investment decisions.
- Impact of Financial Costs: The significant impact of rising finance costs and foreign exchange losses on Chemtrade's financial condition raises concerns among investors regarding the company's future growth potential.
See More
Chemed Acquires Texas Roto-Rooter Franchise for $12 Million
- Acquisition Deal: Chemed Corporation has acquired a formerly independent Roto-Rooter franchise for approximately $12 million, covering 21 counties in South Texas, including cities like Corpus Christi, McAllen, Laredo, and Brownsville, thereby expanding its market presence.
- Market Leadership: This acquisition is expected to enhance Chemed's service capabilities in Texas, as Roto-Rooter is the nation's leading provider of plumbing and drain cleaning services, which may improve the company's overall business performance and customer base.
- Strategic Implications: By integrating this franchise, Chemed aims to optimize resource allocation and enhance service efficiency, thereby maintaining a competitive edge in a crowded market and meeting the growing customer demand.
- Future Outlook: Chemed's announcement includes caution regarding forward-looking statements, indicating that future performance may be influenced by various factors, urging investors to be aware of potential risks associated with these projections.
See More
Barington Capital Accumulates Stake in Chemed and Proposes New Director
- Investor Stake Increase: Barington Capital has accumulated a stake in Chemed (CHE) and proposed former Cerberus Capital Management CEO Chan Galbato as a new board member, indicating confidence in the company's future prospects.
- Management Discussions: Barington has engaged in talks with Chemed's management regarding the potential addition of a new director, highlighting its focus on corporate governance and possibly prompting strategic adjustments within the company.
- Stock Price Reaction: Following the news, Chemed's stock rose by 2%, reflecting a positive market perception of Barington's involvement, despite a 27% decline in stock price over the past year.
- Dividend Declaration: Chemed declared a dividend of $0.60 per share, demonstrating the company's ability to maintain cash flow and shareholder returns in the current market environment.
See More
Chemed Declares $0.60 Quarterly Dividend, Consistent with Previous Payments
- Dividend Declaration: Chemed has declared a quarterly dividend of $0.60 per share, consistent with previous payments, indicating the company's stable cash flow and profitability, which enhances investor confidence.
- Yield Metrics: The forward yield of 0.54% reflects the company's attractiveness in the current market environment, potentially drawing in more investors seeking stable income.
- Payment Schedule: The dividend is payable on June 16, with a record date of May 28 and an ex-dividend date also on May 28, ensuring shareholders receive their returns promptly, thereby reinforcing shareholder loyalty.
- Consistent Payout Record: Chemed has now announced a $0.60 dividend for four consecutive quarters, demonstrating the company's ongoing commitment to shareholder returns, which may enhance its market position within the healthcare sector.
See More
Chemed Corporation Elects Directors and Declares Dividend at 2026 Annual Meeting
- Board Election: At the 2026 annual meeting, Chemed Corporation's shareholders elected a slate of nine directors, ensuring stability in the governance structure and supporting future strategic decision-making.
- Auditor Reappointment: Shareholders unanimously ratified the continuation of PricewaterhouseCoopers as the independent accountants for 2026, reflecting a commitment to financial transparency and compliance, which enhances investor confidence.
- Shareholder Proposal Rejection: The non-binding proposal regarding executive compensation was not approved, indicating shareholder scrutiny over the company's executive pay policies, which may prompt a review and adjustment of compensation structures in the future.
- Quarterly Cash Dividend: The Board declared a cash dividend of 60 cents per share, payable on June 16, 2026, marking the 220th consecutive quarterly dividend, which underscores Chemed's consistent profitability and commitment to shareholder returns over its 55-year history.
See More
U.S. Temporarily Blocks New Home Health Providers from Medicare Enrollment
- New Medicare Regulations: The U.S. government plans to temporarily block new home health and hospice providers from enrolling in Medicare on Wednesday, reflecting a stringent regulatory approach to combat fraud linked to government-backed healthcare programs.
- Nationwide Moratorium: This nationwide pause aims to address healthcare scams, particularly those affecting Medicare, and is expected to enhance transparency and compliance within the healthcare service sector.
- Anti-Fraud Task Force Actions: Vice President JD Vance's anti-fraud task force will announce several policy changes, emphasizing the crackdown on large-scale fraud, which aims to protect the interests of the American public and demonstrates a zero-tolerance stance towards healthcare fraud.
- Industry-Wide Impact: This move could significantly affect major home health and hospice providers, including BrightSpring Health Services and UnitedHealth, prompting companies within the industry to strengthen compliance measures in response to the new regulatory environment.
See More
Chemtrade Logistics Income Fund Reports Q1 Earnings Decline
- Net Earnings Decline: Chemtrade Logistics Income Fund reported Q1 net earnings of C$25.4 million, a significant decrease of C$23.7 million year-over-year, primarily due to rising finance costs and unfavorable unrealized foreign exchange losses, indicating financial pressure on the company.
- Revenue Performance: The total revenue for Q1 reached C$503 million, showing growth compared to the previous year; however, this increase was insufficient to offset the rising costs, reflecting intensified market competition.
- Adjusted EBITDA Decrease: Adjusted EBITDA stood at C$113.5 million, down C$6.6 million or 5.5% year-over-year, highlighting challenges in profitability that may impact future investment decisions.
- Impact of Financial Costs: The significant impact of rising finance costs and foreign exchange losses on Chemtrade's financial condition raises concerns among investors regarding the company's future growth potential.
See More
